LHC Group, Inc. (NASDAQ:LHCG) Director Coliseum Capital Management, L sold 8,632 shares of the company’s stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $60.25, for a total transaction of $520,078.00. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Coliseum Capital Management, L also recently made the following trade(s):

  • On Thursday, May 11th, Coliseum Capital Management, L sold 128,000 shares of LHC Group stock. The stock was sold at an average price of $60.99, for a total transaction of $7,806,720.00.
  • On Friday, March 17th, Coliseum Capital Management, L sold 51,900 shares of LHC Group stock. The stock was sold at an average price of $50.26, for a total transaction of $2,608,494.00.

Shares of LHC Group, Inc. (NASDAQ:LHCG) opened at 59.51 on Friday. LHC Group, Inc. has a 52 week low of $32.04 and a 52 week high of $66.30. The firm has a 50-day moving average of $55.81 and a 200 day moving average of $48.64. The company has a market cap of $1.09 billion, a P/E ratio of 27.55 and a beta of 0.99.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings results on Wednesday, March 8th. The health services provider reported $0.58 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.57 by $0.01. The firm had revenue of $235.44 million for the quarter, compared to the consensus estimate of $233.82 million. LHC Group had a net margin of 3.84% and a return on equity of 9.59%. The company’s revenue for the quarter was up 7.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.53 EPS. Equities analysts anticipate that LHC Group, Inc. will post $2.28 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for LHC Group (NASDAQ:LHCG)

ILLEGAL ACTIVITY NOTICE: This piece of content was originally posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/05/21/lhc-group-inc-lhcg-director-sells-520078-00-in-stock.html.

A number of equities analysts have recently issued reports on LHCG shares. Royal Bank of Canada reiterated a “buy” rating and set a $69.00 target price on shares of LHC Group in a research report on Monday, May 15th. Jefferies Group LLC upped their target price on shares of LHC Group from $56.00 to $65.00 and gave the stock a “buy” rating in a research report on Monday, May 15th. SunTrust Banks, Inc. raised shares of LHC Group from a “hold” rating to a “buy” rating and boosted their price target for the stock from $50.00 to $56.00 in a research note on Friday, March 10th. Benchmark Co. began coverage on shares of LHC Group in a research note on Friday, January 27th. They set a “buy” rating and a $55.00 price target for the company. Finally, Craig Hallum set a $57.00 price target on shares of LHC Group and gave the stock a “buy” rating in a research note on Saturday, March 11th. Eight research analysts have rated the stock with a buy rating, The company currently has an average rating of “Buy” and an average price target of $62.25.

Several hedge funds and other institutional investors have recently modified their holdings of LHCG. Kornitzer Capital Management Inc. KS increased its position in shares of LHC Group by 20.6% in the third quarter. Kornitzer Capital Management Inc. KS now owns 35,100 shares of the health services provider’s stock worth $1,294,000 after buying an additional 6,000 shares during the period. Hood River Capital Management LLC increased its position in shares of LHC Group by 14.8% in the third quarter. Hood River Capital Management LLC now owns 196,855 shares of the health services provider’s stock worth $7,260,000 after buying an additional 25,339 shares during the period. BlackRock Investment Management LLC increased its position in shares of LHC Group by 0.8% in the third quarter. BlackRock Investment Management LLC now owns 70,264 shares of the health services provider’s stock worth $2,591,000 after buying an additional 569 shares during the period. BlackRock Fund Advisors increased its position in shares of LHC Group by 15.6% in the third quarter. BlackRock Fund Advisors now owns 1,133,153 shares of the health services provider’s stock worth $41,791,000 after buying an additional 152,897 shares during the period. Finally, SG Americas Securities LLC purchased a new position in shares of LHC Group during the third quarter worth about $438,000. Hedge funds and other institutional investors own 82.10% of the company’s stock.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

12 Month Chart for NASDAQ:LHCG

Receive News & Ratings for LHC Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.